Plantarflexion Reduces Urgency and Peak Detrusor Pressure in Patients With Detrusor Overactivity

计划入组 22 人 · 首次发布于 2013 年 4 月 23 日

516-BOTOX Urinary Incontinence Detrusor

首次发布于 2009 年 2 月 25 日

Noninvasive Ultrasound Assessment of Detrusor Dysfunction

计划入组 2,023 人 · 首次发布于 2022 年 12 月 15 日

Mirabegron(Myrbetriq, Betmiga)

C₂₁H₂₄N₄O₂S · Rx

Oxybutynin(Ditropan, Gelnique, Kentera, Oxytrol, Kentera (previously Oxybutynin Nicobrand))

C₂₂H₃₁NO₃ · Rx

EG 427's DNA Therapy EG110A Maintains 88% Reduction in Neurogenic Bladder Incontinence at 24 Weeks

EG 427 Secures €27M Series B to Advance Novel Gene Therapy for Spinal Cord Injury-Related Bladder Dysfunction

MSN Labs Receives Regulatory Approval for Phase III Trial of Vibegron 75 mg in Overactive Bladder